Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tribulus saponins capsule for cerebral infarction recovery
ChiCTR1800014632Phase 4Recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Jan 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tribulus saponins in brain infarction, sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: Modified Rankin Scale. Started Jan 2017; status: recruiting.
02
Drugs
tribulus saponins
03
Conditions
brain infarction
Beyond the preview
Go deeper on ChiCTR1800014632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014632.